Can AI remedy the growing pains of digital biomarker development?
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
By
Features (web)
Latest in
Features (web)
Why aren’t digital pills taking off?
While ingestible sensors offer a chance to improve adherence, their use in vulnerable populations remains rife with challenges.
By
Magazine: How noninvasive NASH tests can move the needle
In this issue, we take a look at noninvasive tests in NASH, the future of ALS devices, monkeypox testing kits,…
By
Internet of Things: a tsunami of clinical trial data
IoT devices allow sponsors to access an unprecedented volume and variety of data, but are they equipped to ride the…
By
The future of ALS devices: next gen assistive technology aims to give patients a voice
Brain-computer interfaces, IoT and AI to fuel the advancement of assistive technology devices for ALS patients.
By
Beyond biopsy: how noninvasive NASH tests can move the needle
There are a variety of noninvasive NASH tests currently available and under investigation—but how can they be optimised?
BySecuring the future foundation for a digital NHS
Matt Barnes, Maintel’s Head of Health & Housing, shares his vision for an IT network architecture fit for the NHS’…
Magazine: is the metaverse the next frontier in clinical trials?
In this issue: Clinical trials in the metaverse, making LFTs sustainable, foreign direct investment in medical devices and the affordability…
By